Pelthos Therapeutics Inc.
Organization details
- Legal name
- Pelthos Therapeutics Inc.
- Former names
- Channel Therapeutics Corp Chromocell Therapeutics Corp
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Nevada
- Headquarters city
- Durham
- Headquarters state / province
- North Carolina
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- PTHS
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0001919246
- EIN
- 86-3335449
Board of directors
-
Andrew J. Einhorn · DirectorSince 2025
-
Chia-Lin Simmons · DirectorSince 2024
-
Ezra M. Friedberg · DirectorSince 2024
-
Matthew Pauls · DirectorSince 2025
-
Peter Greenleaf · DirectorSince 2025
-
Richard B. Baxter · DirectorSince 2025
-
Richard Malamut · DirectorSince 2024
-
Scott M. Plesha · Director · CEO and PresidentSince 2025
-
Todd C. Davis · DirectorSince 2024
Chief executives
Director election results
Annual meeting of September 29, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
100.0%
-
100.0%
Board connections
3 of this board's directors also sit on 5 other boards. 5 are in the same sector.
-
Palvella Therapeutics Inc. Same sectorvia Matthew Pauls and Todd C. Davis
-
Altimmune Inc. Same sectorvia Peter Greenleaf
-
Aurinia Pharmaceuticals Inc Same sectorvia Peter Greenleaf
-
Ligand Pharmaceuticals Incorporated Same sectorvia Todd C. Davis
-
Savara Inc. Same sectorvia Matthew Pauls
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $999,822
- 2 purchases by 1 insider
- Sold, last 12 months
- $486,292
- 24 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 2, 2026 | Ezra M. Friedberg Director | Open-market sale | −558 | $20.72 | $11,560 |
| Oct 2, 2026 | Peter Greenleaf Director | Open-market sale | −797 | $21.17 | $16,872 |
| Oct 2, 2026 | Matthew Pauls Director | Open-market sale | −786 | $21.00 | $16,506 |
| Jul 2, 2026 | Ezra M. Friedberg Director | Open-market sale | −534 | $26.03 | $13,900 |
| Jul 2, 2026 | Peter Greenleaf Director | Open-market sale | −712 | $26.00 | $18,512 |
| Jul 2, 2026 | Matthew Pauls Director | Open-market sale | −692 | $26.00 | $17,992 |
| Jul 2, 2026 | Ezra M. Friedberg Director | Open-market sale | −24 | $27.33 | $656 |
| Jul 2, 2026 | Peter Greenleaf Director | Open-market sale | −85 | $27.27 | $2,318 |
| Jul 2, 2026 | Matthew Pauls Director | Open-market sale | −94 | $27.36 | $2,572 |
| Jun 15, 2026 | Ezra M. Friedberg Director | Open-market sale | −224 | $27.12 | $6,075 |
| Jun 15, 2026 | Ezra M. Friedberg Director | Open-market sale | −59 | $27.94 | $1,648 |
| Jun 11, 2026 | Todd C. Davis Director | Open-market purchase | +35,445 | $27.80 | $985,371 |
| Jun 11, 2026 | Todd C. Davis Director | Open-market purchase | +503 | $28.73 | $14,451 |
| May 22, 2026 | Knuettel Francis II Officer (CFO, Treas & Secty) | Sold back to the company | −13,947 | — | — |
| May 22, 2026 | Knuettel Francis II Officer (CFO, Treas & Secty) | Open-market sale | −1,500 | $26.84 | $40,260 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Pelthos Therapeutics Inc.
Who is the CEO of Pelthos Therapeutics Inc.?
Scott M. Plesha has been Pelthos Therapeutics Inc.'s CEO and President since July 2025.
How many directors are on Pelthos Therapeutics Inc.'s board?
Pelthos Therapeutics Inc.'s board has 9 directors: Andrew J. Einhorn, Chia-Lin Simmons, Ezra M. Friedberg, Matthew Pauls, Peter Greenleaf, Richard B. Baxter, Richard Malamut, Scott M. Plesha and Todd C. Davis.
Are Pelthos Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Pelthos Therapeutics Inc. insiders bought $999,822 of shares in 2 purchases and sold $486,292 of shares in 24 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="pelthos-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.